This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Albemarle (ALB) to Set up Lithium Technology Park in Charlotte
by Zacks Equity Research
Albemarle (ALB) acquires a location in Charlotte, NC, to establish Albemarle Technology Park and quicken the release of the latest lithium products.
RSPositive Net Change ALBNegative Net Change SQMPositive Net Change IOSPPositive Net Change
basic-materials
Schwab (SCHW) Records a Fall in November Core Net New Assets
by Zacks Equity Research
Schwab (SCHW) records core net new assets of $33.1 billion in November 2022, down 21% sequentially and 27% year over year.
SCHWPositive Net Change IBKRPositive Net Change LPLAPositive Net Change
finance
Tullow (TUWOY) Signs Ivory Coast Offshore Exploration Contract
by Zacks Equity Research
Tullow (TUWOY) announces the signing of a production sharing contract for Ivory Coast's offshore exploration license CI-803.
SLBNegative Net Change HALNegative Net Change REPYYNegative Net Change TUWOYPositive Net Change
energy oil-energy
Here's Why Hold Strategy is Apt for Kinder Morgan (KMI) Now
by Zacks Equity Research
Kinder Morgan (KMI) expects higher adjusted core earnings for 2023 as it banks on the higher demand for transporting crude oil, gas liquids and carbon dioxide.
HALNegative Net Change PTENNegative Net Change HPNegative Net Change KMIPositive Net Change
energy oil-energy
Equinor (EQNR) Puts Johan Sverdrup Phase 2 Project Online
by Zacks Equity Research
At the plateau, the Equinor-operated (EQNR) Johan Sverdrup field will produce 720,000 barrels of oil per day, aiming to rise to 755,000 barrels per day.
OIINegative Net Change RESPositive Net Change LBRTNegative Net Change EQNRNegative Net Change
energy oil-energy
Here's How Rite Aid (RAD) is Placed Just Ahead of Q3 Earnings
by Zacks Equity Research
Higher non-COVID prescriptions, strength in PBM and the expansion of delivery services are likely to Rite Aid's (RAD) Q3 results amid sluggishness in the Retail Pharmacy and Pharmacy Services segments.
RADNegative Net Change CCLNegative Net Change NKEPositive Net Change GISPositive Net Change
retail
Factors Likely to Influence NIKE's (NKE) Earnings in Q2
by Zacks Equity Research
NIKE's (NKE) Q2 results are likely to reflect gains from strong demand, digital momentum and product innovation, offset by rising costs, higher markdowns and adverse currency effects.
CCLNegative Net Change NKEPositive Net Change GISPositive Net Change LMNRPositive Net Change
consumer-discretionary
Is Cirrus Logic (CRUS) a Great Stock for Value Investors?
by Zacks Equity Research
Is Cirrus Logic (CRUS) a great pick from the value investor's perspective right now? Read on to know more.
CRUSPositive Net Change
computers
Subscription Revenues to Boost NY Times' (NYT) Growth in 2023
by Zacks Equity Research
The New York Times Company (NYT) expects total fourth-quarter subscription revenues to increase about 17-20%.
CRMNegative Net Change NYTPositive Net Change WWEPositive Net Change RSVRPositive Net Change
consumer-staples
Shell (SHEL) to Sell Interest in Baram Delta Offshore Malaysia
by Zacks Equity Research
Shell (SHEL) agrees to sell its non-operated stake in two offshore production sharing contracts in the Baram Delta to Petroleum Sarawak Exploration & Production.
RESPositive Net Change ENLCNegative Net Change SHELNegative Net Change
energy oil-energy
B&G Foods' (BGS) Sale of Back to Nature to Enhance Structure
by Zacks Equity Research
B&G Foods (BGS) inks a deal to sell its Back to Nature brand to Barilla America. The divestiture is expected to be concluded in the first quarter of 2023.
CAGPositive Net Change MKCPositive Net Change BGSNo Net Change CHEFPositive Net Change
consumer-staples
SAIC Wins $150M Airport Technology Support Contract From TSA
by Zacks Equity Research
Per the latest $150 million contract from the TSA, SAIC is likely to continue performing the operational testing and evaluation of TSA airport screening equipment and non-screening systems.
CLSPositive Net Change BLKBPositive Net Change SAICPositive Net Change ZSPositive Net Change
computers tech-stocks
Raytheon (RTX) Wins Deal to Supply F135 Propulsion System Parts
by Zacks Equity Research
Raytheon (RTX) is set to supply long-lead materials, parts and components for the 17th lot's F135 propulsion systems to support the F-35 Lighting II Joint Strike Fighter aircraft.
LMTPositive Net Change NOCPositive Net Change BAESYNegative Net Change RTXPositive Net Change
aerospace
3 Lucrative Growth Stocks Down More Than 30% YTD to Buy Now
by Kaibalya Pravo Dey
Macroeconomic volatility leading to price fall for numerous stocks is creating major investment opportunities. Zscaler, DocuSign and Caesars Entertainment have tremendous growth opportunities.
CZRPositive Net Change DOCUPositive Net Change ZSPositive Net Change
business-services computers consumer-discretionary
Why You Should Add CBIZ (CBZ) Stock to Your Portfolio Now
by Zacks Equity Research
CBIZ (CBZ) is benefiting from strong organic revenue growth as well as contributions from recent acquisitions.
CRAIPositive Net Change CBZPositive Net Change BAHPositive Net Change
business-services
Is it Wise to Retain UDR Stock in Your Portfolio for Now?
by Zacks Equity Research
UDR's geographically diverse portfolio, technological moves and healthy balance-sheet position bode well for growth. However, a huge development outlay and interest rate hikes are key woes.
LAMRPositive Net Change UDRPositive Net Change CLDTPositive Net Change VICIPositive Net Change
finance reit
Here's Why Radian Group (RDN) Stock is an Attractive Bet Now
by Zacks Equity Research
Radian Group (RDN) is poised to grow due to well-performing real estate services and valuation products, favorable growth estimates and effective capital deployment.
MTGPositive Net Change RDNPositive Net Change ALIZYNo Net Change ROOTNegative Net Change
insurance
Here's Why You Should Retain RLI Stock in Your Portfolio
by Zacks Equity Research
RLI stands to gain from compelling product portfolio, sustained rate increase, expanded distribution and operational strength and sufficient liquidity.
RLIPositive Net Change WRBPositive Net Change KNSLPositive Net Change ROOTNegative Net Change
insurance
4 Restaurant Stocks to Watch as Sales Continue to Soar
by Ritujay Ghosh
Stocks like Wingstop Inc. (WING), Dine Brands Global, Inc. (DIN), Chuy's Holdings, Inc. (CHUY) and BJ's Restaurants, Inc. (BJRI) are expected to benefit in the near term as sales continue to increase.
BJRINegative Net Change DINNegative Net Change CHUYPositive Net Change WINGPositive Net Change
restaurants
3 REITs With Recent Dividend Hikes to Help Survive Market Volatility
by Moumita C. Chattopadhyay
Ushering in good news for investors, particularly income-seeking ones, recently, a number of REITs declared their dividend hikes. Among them are O, ARE and MAA.
MAAPositive Net Change OPositive Net Change AREPositive Net Change
finance reit
CrowdStrike (CRWD) Brings Falcon Surface EASM Solution
by Zacks Equity Research
CrowdStrike (CRWD) launches Falcon Surface, industry's most complete adversary-driven external attack surface management solution and strengthens its position in the security and IT operations space.
CLSPositive Net Change PANWPositive Net Change FNPositive Net Change CRWDPositive Net Change
tech-stocks
Ciena's (CIEN) Coherent Optical Technology Used by Dedicado
by Zacks Equity Research
Ciena's (CIEN) 6500 Packet-Optical Platform powered by WL5e is used by Dedicado to support the rising demand for network connectivity.
CIENPositive Net Change PLXSPositive Net Change SMCINegative Net Change ANETPositive Net Change
tech-stocks
Pharma Stock Roundup: LLY's 2023 View, MRK-MRNA Joint Cancer Vaccine Data & More
by Kinjel Shah
Eli Lilly (LLY) gives its financial guidance for 2023. Merck (MRK) and Moderna's (MRNA) mRNA-based cancer vaccine shows positive results in a joint study.
SNYNegative Net Change NVSPositive Net Change MRKPositive Net Change LLYPositive Net Change MRNANegative Net Change
pharmaceuticals
4 Drug Stocks Up More Than 40% YTD With Room to Grow in 2023
by Kinjel Shah
Here are four drug companies, MRK, VRTX, IMCR and IMVT, that are up 40% or more in 2022 so far and still have room for growth in 2023.
MRKPositive Net Change VRTXPositive Net Change IMVTNegative Net Change IMCRPositive Net Change
biotechs pharmaceuticals
3 Permian Explorers to Gain as Oil Price Remains Healthy
by Nilanjan Banerjee
Exploration and production businesses are witnessing big gains on the back of a healthy crude price trajectory. This will benefit Diamondback (FANG), Pioneer (PXD) & Matador (MTDR).
PXDPositive Net Change FANGNegative Net Change MTDRNegative Net Change
oil-energy